CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

A visual look at Wall Street's Santa Claus rallies since 2000, even as such a rally comes under pressure on Thursday. Read ...

AliExpress International and South Korea-based E-Mart's e-commerce platform Gmarket are forming a 50-50 joint venture in ...

Gap is on the rise, with strong Q3 results signaling a turnaround. It trades at just 11.9x fwd P/E, well below the industry ...

Nokian grew underlying earnings regardless prior to the rapid production ramp-up. Its Romanian factory will start production ...

Trainline is capitalizing on the digitization of rail travel with a 17% sales increase. See why we recommend a buy rating on ...

Green Dot is poised for growth with strong FCF yield and market positions, but faces risks from retail declines and customer ...

Green Brick's Q3 2024 revenues were $523 million, which is a 25.7% increase YoY. It offers the possibility of buying a solid ...

Read thorough research and investment insights by Garvit Bhandari on Seeking Alpha here. View their credentials, investment ...

Melco Resorts' Q324 shows improvement. Substantial debt and upcoming maturities pose significant financial risks. Read an ...

TFLO is a top choice for reliable income investing, offering stability and above-average yields in uncertain market ...

Dropbox has had a nice run, but the honeymoon period of people defaulting into their premium tier appears to be over. Read ...